CJC-1295/IPA

Overview:

CJC-1295 (without DAC) and Ipamorelin are synthetic peptides studied for their synergistic activity in growth hormone–releasing pathways. CJC-1295 is a GHRH analog, while Ipamorelin is a selective GHRP agonist. Together, they are being researched for their ability to promote pulsatile GH release in experimental models.

Specifications:

• Unit Size: 10 mg (vial)

• Storage (Lyophilized): Cool, dry place.

• Storage (Reconstituted): 36°F–46°F (2°C–8°C).

Areas of Scientific Interest:

• Growth hormone secretion patterns

• Sleep, recovery, and cellular repair research

• Synergistic endocrine modulation studies

⚠️ For Research Use Only

Not for human or animal consumption.

Disclaimer:

For lawful laboratory use by qualified professionals only. Not evaluated by the FDA.

Terms of Sale:

Purchaser agrees to proper handling, storage, and compliance. All sales are final.